Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-079610
Filing Date
2025-08-18
Accepted
2025-08-18 10:16:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5515
  Complete submission text file 0001104659-25-079610.txt   7350
Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Subject) CIK: 0001826667 (see all company filings)

EIN.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91951 | Film No.: 251226733
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address SADDLERS' HOUSE 5TH FLOOR, 44 GUTTER LANE, LONDON X0 EC2V 6BR
Business Address SADDLERS' HOUSE 5TH FLOOR, 44 GUTTER LANE, LONDON X0 EC2V 6BR 02038614361
Utmost Group Plc (Filed by) CIK: 0002046077 (see all company filings)

EIN.: 616132186 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13G